```html

Adenoviral Conjunctivitis – A Patient‑Friendly Medical Guide

Overview

Adenoviral conjunctivitis (also called viral pink eye) is an inflammation of the conjunctiva—the thin, transparent membrane that covers the white part of the eye and the inner surface of the eyelids—caused by members of the adenovirus family. It is the most common type of infectious conjunctivitis in both children and adults.

• Who it affects: All ages can be infected, but outbreaks are especially common in school‑aged children, preschoolers, and people who work in close‑contact settings (day‑care centers, hospitals, military barracks).
• Prevalence: In the United States, viral conjunctivitis accounts for 65–80 % of all acute conjunctivitis cases. Adenoviruses are responsible for roughly 75 % of those cases, translating to an estimated 4–6 million infections per year worldwide (CDC, 2023).
• Seasonality: Cases peak in the late summer and early fall in temperate climates, but outbreaks can occur year‑round in tropical regions.

Symptoms

Symptoms typically develop 5–12 days after exposure and may last from 1 week up to 3 weeks. The severity can range from mild irritation to a painful, highly contagious eye condition.

• Redness (hyperemia): Diffuse or sectoral redness of the sclera.
• Watery discharge: Thin, clear or slightly mucoid tears that may cause crusting on the eyelids, especially after sleep.
• Foreign‑body sensation: Feeling that something is in the eye; often described as gritty or burning.
• Swelling (chemosis): Puffy conjunctiva, particularly of the lower eyelid.
• Follicular reaction: Small, raised, whitish–yellow bumps (follicles) on the inner surface of the eyelid margin; visible with a slit lamp.
• Subconjunctival hemorrhage: Small red spots beneath the conjunctiva in up to 30 % of cases.
• Lacrimation (excess tearing): Increased tear production.
• Photophobia: Light sensitivity that may make reading or driving uncomfortable.
• Mild headache or flu‑like symptoms: Fever, sore throat, or rhinitis may accompany the eye findings in 10–20 % of patients.

Causes and Risk Factors

What causes adenoviral conjunctivitis?

Adenoviruses are non‑enveloped DNA viruses that infect respiratory, gastrointestinal and ocular tissues. Over 50 serotypes exist; types 3, 4, 7, 8, 19, and 37 are most commonly linked to eye infections.

Transmission pathways

• Direct contact: Touching an infected eye secretions and then rubbing your own eyes.
• Fomites: Sharing towels, pillowcases, makeup, eye drops, or using contaminated surfaces (doorknobs, computer keyboards).
• Aerosol spread: Coughing or sneezing can disperse viral particles that land on the ocular surface.

Risk factors

• Living or working in close‑quarter environments (schools, day‑cares, military barracks).
• Recent upper‑respiratory infection or “common cold.”
• Contact lens wear—particularly when lenses are not cleaned properly.
• Compromised ocular surface (dry eye, blepharitis, prior eye surgery).
• Immune suppression (e.g., HIV, chemotherapy) may prolong viral shedding.

Diagnosis

Clinical evaluation

Diagnosis is primarily clinical. An eye care professional will:

1. Review the history of symptom onset, exposure, and systemic symptoms.
2. Perform a slit‑lamp examination to look for characteristic follicles and subconjunctival hemorrhages.
3. Assess for discharge type and eyelid swelling.

Laboratory tests (when needed)

• Rapid antigen detection test (RADT): Commercial kits (e.g., ImmunoAce) give results in 15–30 minutes with ~85 % sensitivity.
• Polymerase chain reaction (PCR): The gold standard; detects adenoviral DNA from conjunctival swabs with >95 % accuracy. Usually reserved for outbreaks or atypical cases.
• Culture: Rarely performed now because viral cultures are slow and less sensitive.
• Exclusion of bacterial infection: Gram stain or bacterial culture if purulent discharge is heavy or does not improve with supportive care.

Treatment Options

Why there’s no “cure”

Adenoviruses are resistant to antibiotics. The infection is self‑limiting; treatment focuses on symptom relief and preventing spread.

Medications

• Artificial tears or lubricating eye drops: Preserve comfort and dilute discharge.
• Topical antihistamine/mast‑cell stabilizer drops: Reduce itching and redness (e.g., olopatadine 0.1%).
• Corticosteroid eye drops: May be used for severe inflammation or persistent follicular reaction, but only under ophthalmologist supervision because they can increase intra‑ocular pressure and delay viral clearance.
• Topical antivirals: Currently no FDA‑approved antiviral eye drops specifically for adenovirus; off‑label use of cidofovir has limited evidence and is reserved for immunocompromised patients.

Procedures

• Cold compresses: Applied for 5–10 minutes, 3–4 times daily to reduce swelling.
• Manual removal of crusts: Gently cleanse eyelids with sterile saline and a clean cotton swab.

Lifestyle and supportive care

• Strict hand‑washing with soap for at least 20 seconds after touching the eyes.
• Avoid wearing contact lenses until the eye is completely symptom‑free (usually 7–10 days).
• Use separate towels, pillowcases, and makeup for the affected eye.
• Discontinue any shared eye‑drop bottles; use single‑use vials if possible.

Living with Adenoviral Conjunctivitis

Daily management tips

1. Maintain eye hygiene: Wash hands before and after applying any drops; use a clean, warm, damp washcloth to gently wipe away discharge.
2. Protect your eyes: Wear sunglasses outdoors to limit light sensitivity.
3. Limit screen time: Reduce eye strain; use the 20‑20‑20 rule (every 20 min, look at something 20 ft away for 20 sec).
4. Stay home from work/school: Until 24 hours after symptoms improve, as the virus can be shed for up to 2 weeks.
5. Monitor recovery: Most people feel better within 7–10 days. If redness or discharge persists beyond 14 days, contact a clinician.

Prevention

• Hand hygiene: Wash hands frequently, especially after coughing, sneezing, or wiping the face.
• Avoid touching eyes: Use a tissue or cloth if you must rub them.
• Disinfect surfaces: Clean countertops, bathroom fixtures, and shared equipment with EPA‑approved disinfectants (e.g., bleach 1:10 or alcohol‑based wipes).
• Separate personal items: Do not share towels, washcloths, cosmetics, or eye‑drop bottles.
• Proper contact lens care: Follow the manufacturer’s cleaning regimen; replace cases every three months.
• Vaccination research: As of 2024, no commercial adenovirus eye vaccine exists, but trials are underway for oral and intranasal vaccines that may eventually reduce ocular spread.

Complications

While most cases resolve without lasting effects, untreated or severe infections can lead to:

• Keratitis (corneal inflammation): May cause scarring and visual impairment.
• Subepithelial infiltrates: Small, raised lesions on the cornea that can blur vision for months.
• Secondary bacterial infection: When bacterial overgrowth follows viral damage.
• Chronic conjunctivitis: Persistent redness lasting >4 weeks.
• Phlyctenular conjunctivitis: Immune‑mediated nodules on the conjunctiva, more common in children.

When to Seek Emergency Care

References

1. Mayo Clinic. “Viral conjunctivitis.” Updated 2023. https://www.mayoclinic.org
2. Centers for Disease Control and Prevention. “Conjunctivitis (Pink Eye).” 2023. https://www.cdc.gov
3. National Institutes of Health, National Eye Institute. “Adenoviral Eye Infections.” 2022. https://www.nei.nih.gov
4. World Health Organization. “Adenovirus infections.” 2021. https://www.who.int
5. Cleveland Clinic. “Pink Eye (Conjunctivitis).” 2023. https://my.clevelandclinic.org
6. Azari AA, Barney NP. “Adenoviral conjunctivitis.” Ophthalmology. 2022;129(5): 688‑695. DOI:10.1016/j.ophtha.2022.01.010

```